Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Immune system and neural tissue' refers to broad physiological systems and anatomical structures rather than a specific molecular drug target such as a protein, enzyme, or receptor (Nature Reviews Drug Discovery, 2006). The interaction between these two systems is the primary focus of neuroimmunology, which explores how immune cells like microglia and astrocytes interact with neurons to maintain homeostasis or drive pathology (NIH, 2023). While the neuro-immune interface is a critical site for therapeutic intervention in conditions like multiple sclerosis and neurodegenerative diseases, the term itself is too broad to serve as a functional target in drug discovery (PubMed, 2021). Effective drug development requires the identification of specific molecular entities, such as cytokines, cell surface receptors, or signaling kinases, within these tissues. Consequently, this entry is classified as incorrect for the purposes of structured target annotation as it describes a biological context rather than a druggable molecule.
Not applicable as this entry describes biological systems rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system and neural tissue.